NBIX vs SHAK · P/E 45, rev $1.77B vs P/E 63, rev $784.4M
Neurocrine Biosciences Inc (NBIX) versus Shake Shack Inc (SHAK) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Shake Shack Inc (SHAK) is a restaurants company listed on NYSE.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported SHAK revenue for 2026-07-01 was $784.4M. Net income was $15.4M. SHAK currently screens at market cap $2.62B and trailing P/E 62.6.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. SHAK currently screens at market cap $2.62B and trailing P/E 62.6.
Not investment advice. Open the NBIX and SHAK stock pages for the full models.
Not investment advice.